Atomistry » Fluorine » PDB 2fq9-2gtm » 2gfs
Atomistry »
  Fluorine »
    PDB 2fq9-2gtm »
      2gfs »

Fluorine in PDB 2gfs: P38 Kinase Crystal Structure in Complex with RO3201195

Enzymatic activity of P38 Kinase Crystal Structure in Complex with RO3201195

All present enzymatic activity of P38 Kinase Crystal Structure in Complex with RO3201195:
2.7.1.37;

Protein crystallography data

The structure of P38 Kinase Crystal Structure in Complex with RO3201195, PDB code: 2gfs was solved by S.F.Harris, J.Bertrand, A.Villasenor, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.00 / 1.75
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 45.292, 86.480, 124.055, 90.00, 90.00, 90.00
R / Rfree (%) 20.5 / 23.9

Fluorine Binding Sites:

The binding sites of Fluorine atom in the P38 Kinase Crystal Structure in Complex with RO3201195 (pdb code 2gfs). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the P38 Kinase Crystal Structure in Complex with RO3201195, PDB code: 2gfs:

Fluorine binding site 1 out of 1 in 2gfs

Go back to Fluorine Binding Sites List in 2gfs
Fluorine binding site 1 out of 1 in the P38 Kinase Crystal Structure in Complex with RO3201195


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of P38 Kinase Crystal Structure in Complex with RO3201195 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F361

b:34.2
occ:1.00
F11 A:PQB361 0.0 34.2 1.0
C10 A:PQB361 1.4 35.2 1.0
C12 A:PQB361 2.4 34.8 1.0
C9 A:PQB361 2.4 34.9 1.0
CD1 A:LEU75 3.2 22.1 1.0
CB A:LEU104 3.2 21.9 1.0
CD1 A:LEU104 3.4 22.2 1.0
C8 A:PQB361 3.7 34.7 1.0
C13 A:PQB361 3.7 34.9 1.0
CD A:LYS53 3.8 29.9 1.0
CG2 A:THR106 3.8 25.1 1.0
CG A:LEU104 3.9 21.7 1.0
OE2 A:GLU71 4.0 27.2 1.0
C7 A:PQB361 4.2 35.9 1.0
CB A:LYS53 4.3 28.7 1.0
O A:LEU104 4.5 22.3 1.0
CA A:LEU104 4.5 22.1 1.0
C A:LEU104 4.5 22.3 1.0
CG A:LEU75 4.5 20.5 1.0
NZ A:LYS53 4.5 31.5 1.0
CG A:LYS53 4.7 29.4 1.0
O A:HOH440 4.8 38.0 1.0
CD2 A:LEU75 4.8 22.4 1.0
CE A:LYS53 4.8 30.8 1.0
CD1 A:LEU86 4.8 23.7 1.0
CD2 A:LEU104 4.8 22.2 1.0
CD A:GLU71 5.0 22.6 1.0

Reference:

D.M.Goldstein, T.A.Alfredson, J.Bertrand, M.F.Browner, K.Clifford, S.Dalrymple, J.Dunn, J.Freire-Moare, S.F.Harris, S.S.Labadie, J.La Fargue, J.M.Lapierre, S.Larrabee, F.Li, E.Papp, D.Mcweeney, C.Ramesha, R.Roberts, D.Rotstein, B.San Pablo, E.Sjogren, O.Y.So, F.X.Talamas, W.Tao, A.Trejo, A.Villasenor, M.Welch, T.Welch, P.Weller, P.E.Whiteley, K.Young, S.Zipfel. Discovery of S-[5-Amino-1-(4-Fluorophenyl)-1H-Pyrazol-4-Yl]-[3-(2, 3-Dihydroxypropoxy)Phenyl]-Methanone (RO3201195), and Orally Bioavailable and Highly Selective Inhibitor of P38 Map Kinase J.Med.Chem. V. 49 1562 2006.
ISSN: ISSN 0022-2623
PubMed: 16509574
DOI: 10.1021/JM050736C
Page generated: Sun Dec 13 11:36:29 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy